Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?

Mokoena, K. 2025. Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV? Unpublished masters thesis. Stellenbosch: Stellenbosch University [online]. Available: https://scholar.sun.ac.za/items/18e3a6ac-5237-49e5-bc6c-4bc507a44998

Saved in:
Bibliographic Details
Main Author: Mokoena, Kheya Reatlegile
Other Authors: Strijdom, Hans
Format: Thesis
Language:English
Published: Stellenbosch : Stellenbosch University 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613769284190208
access_status_str Open Access
author Mokoena, Kheya Reatlegile
author2 Strijdom, Hans
author_browse Mokoena, Kheya Reatlegile
Strijdom, Hans
author_facet Strijdom, Hans
Mokoena, Kheya Reatlegile
author_sort Mokoena, Kheya Reatlegile
collection Thesis
dc_rights_str_mv Stellenbosch University
description Mokoena, K. 2025. Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV? Unpublished masters thesis. Stellenbosch: Stellenbosch University [online]. Available: https://scholar.sun.ac.za/items/18e3a6ac-5237-49e5-bc6c-4bc507a44998
format Thesis
id oai:scholar.sun.ac.za:10019.1/132250
institution Stellenbosch University (South Africa)
language English
last_indexed 2026-06-10T12:41:24.431Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/132250 Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV? Mokoena, Kheya Reatlegile Strijdom, Hans Webster, Ingrid Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Biomedical Sciences. Division of Medical Physiology. Mitochondrial pathology -- South Africa HIV infections -- Complications -- South Africa Cardiovascular system -- Diseases -- South Africa HIV-positive persons -- Health and hygiene -- South Africa UCTD Mokoena, K. 2025. Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV? Unpublished masters thesis. Stellenbosch: Stellenbosch University [online]. Available: https://scholar.sun.ac.za/items/18e3a6ac-5237-49e5-bc6c-4bc507a44998 Thesis (MSc)--Stellenbosch University, 2025. ENGLISH ABSTRACT: Background and Aim: Cardiometabolic disease (CMD) in people living with HIV (PLWH) represents a global concern. HIV-related viral factors and antiretroviral therapy have been previously shown to cause mitochondrial dysfunction, however, the role played by mitochondria in HIV-associated CMD is poorly described, especially in Sub-Saharan Africa. This exploratory study examined the relationships between mitochondrial function, HIV status, and CMD within a South African cohort. Methods: This cross-sectional study consisted of 158 participants, recruited from a healthcare clinic in Worcester (Western Cape). The two main study groups (HIV- and HIV+) were further divided into HIV- with (n=39) and without CMD (n=33), and HIV+ with (n=44) and without CMD (n=42). Demographic, socioeconomic, medical data and anthropometric data were collected. Blood and urine samples were collected for biochemical analysis and for isolating peripheral blood mononuclear cells for mitochondrial analysis via high-resolution respirometry (Oroboros®). CMD was defined as having 3 or more of a pre-determined set of cardiovascular and metabolic risk factors. Data were statistically analysed with SPSS Version 29.0(241) software. Results: The cohort was relatively young (<42 years) and consisted mostly of women (HIV-: 70.8%, HIV+: 77.9%), with high smoking rates. Liver fibrosis marker (FIB-4: 0.945 [0.19-4.19] vs. 0.605 [0.20-4.04], p<0.001) was higher in HIV+. Routine respiration (O2 consumption: pmol/s/mL) was significantly lower in the HIV+ group vs. HIV- [0.001 (0.001-5.767) vs. 1.694 (0.001-8.050), p<0.001], and positively associated with HbA1c [Standardised β (95%CI): [0.285 (0.030-0.540, p=0.029], whereas residual oxygen consumption (ROX) was higher in HIV+ vs. HIV- [0.312 (0.001-6.330) vs. 0.157 (0.001-4.798), p=0.036]. Routine respiration (H2O2 production: μM) was associated with smoking status [β: 0.335 (0.081-0.590, p=0.011] and HIV duration <10 years [β: 0.311 (0.038-0.584, p=0.026], and inversely associated with FIB-4 [β: -0.470 (-0.769 to -0.171, p=0.011]. The adjusted marginal mean for cytochrome c response (O2 consumption: pmol/s/mL) was lower in HIV+ (0.178 [0.084-0.271] vs. 0.340 [0.237-0.442], p=0.030). Maximal ETS capacity (O2 consumption: pmol/s/mL) was negatively associated with CMD+ status [β: -0.340 (-0.631 to -0.050, p=0.022]. Discussion and conclusion: The findings of our study point to a greater degree of altered mitochondrial function in PLWH compared to their HIV–negative control counterparts, with particular reference to overall mitochondrial health (lower routine respiration), loss of outer membrane integrity (lower cytochrome c response) and increased oxidative side reactions (elevated ROX). H2O2 production was also altered at a number of mitochondrial states. In addition to changes observed between PLWH and HIV-, mitochondrial function was affected by CMD status at some respiratory states. Regression models furthermore demonstrated a number of associations between markers of CMD, HIV duration, and mitochondrial respiratory states in terms of both O2 consumption and H2O2 production. In conclusion, the results of this exploratory study suggest that mitochondrial function may be altered in PLWH and CMD. Our study may pave the way for future longitudinal studies with more diverse and larger cohorts to provide stronger evidence of a role for altered mitochondrial function in PLWH. This could benefit the management of PLWH at risk of mitochondrial dysfunction and CMD. AFRIKAANSE OPSOMMING: Geen opsomming beskikbaar. Masters 2025-05-30T13:46:57Z 2025-05-30T13:46:57Z 2025-03 Thesis https://scholar.sun.ac.za/handle/10019.1/132250 en Stellenbosch University 137 pages : illustrations application/pdf Stellenbosch : Stellenbosch University
spellingShingle Mitochondrial pathology -- South Africa
HIV infections -- Complications -- South Africa
Cardiovascular system -- Diseases -- South Africa
HIV-positive persons -- Health and hygiene -- South Africa
UCTD
Mokoena, Kheya Reatlegile
Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title_full Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title_fullStr Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title_full_unstemmed Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title_short Is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with HIV?
title_sort is mitochondrial dysfunction a putative marker of cardiometabolic disease in people living with hiv
topic Mitochondrial pathology -- South Africa
HIV infections -- Complications -- South Africa
Cardiovascular system -- Diseases -- South Africa
HIV-positive persons -- Health and hygiene -- South Africa
UCTD
url https://scholar.sun.ac.za/handle/10019.1/132250
work_keys_str_mv AT mokoenakheyareatlegile ismitochondrialdysfunctionaputativemarkerofcardiometabolicdiseaseinpeoplelivingwithhiv